Click on the link to read a guide to understanding HER2+ breast cancer.
This guide was sourced from Dr Sara M. Tolaney’s webpage: retrieved 17.12.16 @ 5:50.
Dr. Tolaney is a medical oncologist at Dana-Farber Cancer Institute in Boston, Mass., where she focuses on developing new treatments for breast cancer. She is also a medical instructor at Harvard Medical School.
Dr. Tolaney received her undergraduate degree from Princeton University in 1998 and her medical degree from the University of California, San Francisco in 2002. She completed her residency in internal medicine at Johns Hopkins University and a fellowship in hematology-oncology at the Dana-Farber Cancer Institute.